EUVIMEDEUVIMED entdecken
Crossref

Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease

Yiwen Hou, Yue Wu, Yang Cao, Xiaoxia Hu, Yuqian Sun, Hongmei Wang, Liang Wang, Jialin Zhou, Zhonglin Zhang, Zhiwei Liu, Baolin Tang, Kaidi Song und 8 weitere

Cell · 2025-05 · 188 (11) · 3030-3044.e17

DOI: 10.1016/j.cell.2025.03.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-05. Verfasst von Yiwen Hou und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of USTC, Hefei National Research Center for Physical Sciences at the Microscale, National Key…. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Major Science and Technology Projects of China, Anhui Provincial Department of Education, Scientific Research Foundation of Education Department of Anhui Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a cornerstone treatment for a broad spectrum of malignant and nonmalignant hematological disorders. However, the success of allo-HSCT is often overshadowed by acute graft-versus-host disease (aGVHD), a life-threatening complication. Here, we show in patients and murine models that the circadian timing of stem cell infusion dictates the development of aGVHD. Early-infused patients exhibit a significantly lower incidence and severity of aGVHD, as well as improved survival. We observed time-of-day variations in the levels of cytokines, especially IL-1α, which controls donor T cell responses after transplantation. The levels of IL-1α in patients were strongly associated with the development of aGVHD. Furthermore, preclinical results showed that the administration of IL-1α neutralizing antibodies markedly alleviated aGVHD and increased survival. Our study suggests that scheduling stem cell infusions early in the day could be a simple yet transformative intervention for preventing aGVHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAnimalsInterleukin-1alphaHumansMiceMaleFemaleTransplantation, HomologousAdultMiddle AgedMice, Inbred C57BLTime FactorsAntibodies, NeutralizingAcute DiseaseDisease Models, Animal

Stichwörter der Autor:innen

IL-1αT cell responsesacute graft-versus-host diseaseallogeneic hematopoietic stem cell transplantationcircadian rhythmhaplo-identical donorsmatched sibling donorsstem cell infusion

Substanzen

Interleukin-1alphaAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of USTC, Hefei National Research Center for Physical Sciences at the Microscale, National Key Laboratory of Immune Response and Immunotherapy, Division of Life Sci…
  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Blood and Marrow Transplantation Center, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shangha…
  • Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, Chin…
  • Department of Pediatrics, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
  • Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.

Förderung

  • National Major Science and Technology Projects of China
  • Anhui Provincial Department of Education
  • Scientific Research Foundation of Education Department of Anhui Province of China
  • Natural Science Foundation of Anhui Province
  • National Natural Science Foundation of China
  • Chinese Academy of Sciences

Zitieren

APA

Hou, Y., Wu, Y., Cao, Y., Hu, X., Sun, Y., Wang, H., Wang, L., Zhou, J., Zhang, Z., Liu, Z., Tang, B., Song, K., Sun, G., Gao, W., Zheng, T., Wu, P., Wu, W., Ju, D., Zhu, X., & Zhan, C. (2025). Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease. Cell, 188(11), 3030-3044.e17. https://doi.org/10.1016/j.cell.2025.03.022

Vancouver

Hou Y, Wu Y, Cao Y, Hu X, Sun Y, Wang H, et al. Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease. Cell. 2025;188(11):3030-3044.e17. doi:10.1016/j.cell.2025.03.022

BibTeX
@article{Hou2025,
  author = {Hou, Yiwen and Wu, Yue and Cao, Yang and Hu, Xiaoxia and Sun, Yuqian and Wang, Hongmei and Wang, Liang and Zhou, Jialin and Zhang, Zhonglin and Liu, Zhiwei and Tang, Baolin and Song, Kaidi and Sun, Guangyu and Gao, Wen and Zheng, Tianqi and Wu, Ping and Wu, Weiwei and Ju, Dapeng and Zhu, Xiaoyu and Zhan, Cheng},
  title = {Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {11},
  pages = {3030--3044.e17},
  doi = {10.1016/j.cell.2025.03.022}
}
Kostenlos starten →